Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.160 | 19 | 50406456 | missense variant | G/A | snv |
|
0.800 | 1.000 | 6 | 2013 | 2015 | |||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
0.800 | 1.000 | 4 | 2006 | 2016 | |||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 2006 | 2017 | ||||||||
|
1.000 | 19 | 50408818 | inframe deletion | CTC/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 3 | 2013 | 2015 | |||||||||
|
1.000 | 19 | 50408818 | inframe deletion | CTC/- | delins |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.040 | 19 | 50382924 | 3 prime UTR variant | C/G;T | snv | 0.45 |
|
Infections | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
19 | 50406132 | intron variant | T/A;G | snv | 0.73 | 0.79 |
|
Neoplasms; Nervous System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.080 | 19 | 50401817 | missense variant | G/A | snv | 0.11 | 0.14 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.851 | 0.080 | 19 | 50401817 | missense variant | G/A | snv | 0.11 | 0.14 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.851 | 0.080 | 19 | 50401817 | missense variant | G/A | snv | 0.11 | 0.14 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.851 | 0.080 | 19 | 50401817 | missense variant | G/A | snv | 0.11 | 0.14 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.827 | 0.160 | 19 | 50406456 | missense variant | G/A | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2020 | 2020 | ||||||||
|
0.827 | 0.160 | 19 | 50406456 | missense variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.160 | 19 | 50406456 | missense variant | G/A | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.160 | 19 | 50406456 | missense variant | G/A | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.807 | 0.080 | 19 | 50406444 | missense variant | T/C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
19 | 50409577 | missense variant | C/T | snv | 8.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.925 | 0.080 | 19 | 50402669 | missense variant | C/T | snv | 1.7E-05 | 2.8E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.925 | 0.080 | 19 | 50402669 | missense variant | C/T | snv | 1.7E-05 | 2.8E-05 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
1.000 | 0.080 | 19 | 50417229 | missense variant | C/T | snv | 8.5E-06 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 |